Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Pierre Ledoux

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Blood Advances|May 2, 2022
COVID-19 and hairy-cell leukemia: an EPICOVIDEHA surveySylvain Lamure, Jon Salmanton-García, Elena Robin-Marieton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2025
Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO TrialUwe Platzbecker, Lionel Adès, Pau Montesinos, et al.
Therapeutic Advances in Hematology|March 16, 2023
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registryMonia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, et al.
Frontiers in Oncology|October 24, 2022
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, et al.
Hematological Oncology|December 5, 2023
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registryPellegrino Musto, Jon Salmanton-García, Nicola Sgherza, et al.
Haematologica|May 12, 2022
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)Francesco Marchesi, Jon Salmanton-García, Ziad Emarah, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 20, 2023
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findingsGiuseppe Rossi, Jon Salmanton-García, Chiara Cattaneo, et al.
Journal of Hematology & Oncology|October 15, 2021
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Infection|May 21, 2024
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA surveyTobias Lahmer, Jon Salmanton-García, Francesco Marchesi, et al.
Infection|February 22, 2024
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA surveyTobias Lahmer, Jon Salmanton-García, Francesco Marchesi, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Blood Advances|May 2, 2022
COVID-19 and hairy-cell leukemia: an EPICOVIDEHA surveySylvain Lamure, Jon Salmanton-García, Elena Robin-Marieton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2025
Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO TrialUwe Platzbecker, Lionel Adès, Pau Montesinos, et al.
Therapeutic Advances in Hematology|March 16, 2023
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registryMonia Marchetti, Jon Salmanton-García, Shaimaa El-Ashwah, et al.
Frontiers in Oncology|October 24, 2022
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, et al.
Hematological Oncology|December 5, 2023
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registryPellegrino Musto, Jon Salmanton-García, Nicola Sgherza, et al.
Haematologica|May 12, 2022
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)Francesco Marchesi, Jon Salmanton-García, Ziad Emarah, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 20, 2023
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findingsGiuseppe Rossi, Jon Salmanton-García, Chiara Cattaneo, et al.
Journal of Hematology & Oncology|October 15, 2021
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)Livio Pagano, Jon Salmanton-García, Francesco Marchesi, et al.
Infection|May 21, 2024
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA surveyTobias Lahmer, Jon Salmanton-García, Francesco Marchesi, et al.
Infection|February 22, 2024
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA surveyTobias Lahmer, Jon Salmanton-García, Francesco Marchesi, et al.
Pageof 5